Cargando…
Interest in genomic SNP testing for prostate cancer risk: a pilot survey
BACKGROUND: Advancements in genomic testing have led to the identification of single nucleotide polymorphisms (SNPs) associated with prostate cancer. The clinical utility of SNP tests to evaluate prostate cancer risk is unclear. Studies have not examined predictors of interest in novel genomic SNP t...
Autores principales: | Hall, Michael J, Ruth, Karen J, Chen, David YT, Gross, Laura M, Giri, Veda N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396119/ https://www.ncbi.nlm.nih.gov/pubmed/25874018 http://dx.doi.org/10.1186/s13053-015-0032-3 |
Ejemplares similares
-
Germline testing and genetic counselling in prostate cancer
por: Russo, Jessica, et al.
Publicado: (2022) -
SNP-SNP interactions as risk factors for aggressive prostate cancer
por: Vaidyanathan, Venkatesh, et al.
Publicado: (2017) -
Weight Management to Reduce Prostate Cancer Risk: A Survey of Men’s Needs and Interests
por: Schleper, Amy, et al.
Publicado: (2016) -
HOXB13 and other high penetrant genes for prostate cancer
por: Pilie, Patrick G, et al.
Publicado: (2016) -
A Survey of UK Public Interest in Internet-Based Personal Genome Testing
por: Cherkas, Lynn F., et al.
Publicado: (2010)